Mizuho lowered the firm’s price target on Syndax (SNDX) to $43 from $45 and keeps an Outperform rating on the shares. The firm updated models in the small-cap biotech space following the Q4 reports.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNDX: